Skip to main content

Wellington Management — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

282
Companies
$78.3B
Total invested
$277.6M
Avg. check
70
Industries
Biotechnology 9Health Care 8Medical 7Artificial Intelligence (AI) 7Pharmaceutical 5Therapeutics 5+64 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 1–24 of 282
Kalshi
October 2026

Kalshi operates an online prediction market platform that allows users to trade contracts based on the outcomes of future events.

Financial Exchanges · New York$1.0B Series G
Arcus Biosciences
October 2026

Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.

Biopharma · Hayward$250.0M Post-IPO Equity
Disc Medicine
October 2026

Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.

Biotechnology · Watertown$450.0M Post-IPO Equity
Nscale
September 2026

Nscale builds AI data centers and provides GPU cloud infrastructure that companies use to train, run, and scale large AI models.

AI Infrastructure · London$2.4B Convertible Note
Beta Bionics
September 2026

Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.

Biotechnology · Irvine$172.5M Post-IPO Equity
Temporal Technologies
September 2026

Temporal Technologies is an open-source platform that simplifies building and managing complex, long-running workflows and microservices.

Artificial Intelligence (AI) · Bellevue$550.0M Series E
Clay
September 2026

Clay is a AI go-to-market company building a self-learning revenue engine that helps businesses grow to their full potential.

Artificial Intelligence (AI) · New York$115.0M Series D
Korsana Biosciences
September 2026

Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.

Biopharma · Waltham$380.0M Post-IPO Equity
Databricks
August 2026

Databricks is a data and AI platform that unifies data engineering, analytics, and machine learning on a lakehouse architecture.

Analytics · San Francisco$5.0B Private Equity
Whatnot
August 2026

Whatnot is a live shopping marketplace that connects buyers and sellers through interactive livestreams, auctions, and online storefronts.

Collectibles · Los Angeles$547.0M Series G
Scribe Therapeutics
July 2026

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

Biotechnology · Alameda$7.5M Post-IPO Equity
Crystalys Therapeutics
July 2026

Crystalys Therapeutics is a clinical-stage biopharmaceutical company that develops targeted therapies for gout and hyperuricemia.

Biopharma · San Diego$130.0M Series B
Dyne Therapeutics
July 2026

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

Biotechnology · Cambridge$375.1M Post-IPO Equity
Flex
July 2026

Flex is a financial technology company that offers an end-to-end finance platform that integrates business and personal finance management.

Artificial Intelligence (AI) · San Francisco$70.0M Series B
Fore Biotherapeutics
July 2026

Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.

Biotechnology · Philadelphia$67.4M Series D
Creditas
July 2026

Creditas is a consumer loaning startup that operates a digital platform providing secured loans and low interest rates.

Banking · São Paulo$27.5M Debt Financing
Quantum Systems
July 2026

Quantum Systems builds AI-powered eVTOL drones for defense, security, and surveying, specializing in aerial intelligence solutions.

Aerospace · Gilching$1.2B Series D
Nuvation Bio
June 2026

Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.

Biotechnology · New York$250.0M Post-IPO Debt
RQ Bio
June 2026

RQ Bio is a biotechnology company that develops medicine based on potent broad-spectrum mAbs to provide immunity to viral infections.

Biotechnology · London$112.5M Series A
Baseten
June 2026

Baseten provides the necessary infrastructure, tooling, and expertise to integrate AI into business operations.

AI Infrastructure · San Francisco$1.5B Series F
Current
June 2026

Current is a leading consumer fintech banking platform transforming financial access for everyday Americans.

Banking · New York$80.0M Series E
Urban Company
March 2026

Urban Company provides home cleaning, maintenance, and beauty treatment services conveniently delivered to the doorstep.

Apps · Gurgaon$68.3M Post Ipo Secondary
Quince
March 2026

Quince is an e-commerce company that offers apparel, accessories, home goods, and personal care products through an online platform.

Apparel · San Francisco$500.0M Series E
Span
March 2026

Span develops residential energy storage devices that provide renewable electricity and charging services for electric vehicles.

Energy · San Francisco$75.0M Corporate Round

Where Wellington Management invests

Biotechnology9
Health Care8
Medical7
Artificial Intelligence (AI)7
Pharmaceutical5
Therapeutics5

About Wellington Management's portfolio

How many companies has Wellington Management invested in?▸

Wellington Management has invested in 282 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Wellington Management invest in?▸

Wellington Management's top investment sectors include Biotechnology, Health Care, Medical, Artificial Intelligence (AI), Pharmaceutical. The firm invests across 70 different industry categories.

What is Wellington Management's largest investment?▸

Among tracked funding rounds, Databricks received $5.0B in a Private Equity round. Wellington Management's total known invested capital is $78.3B.

What is the average investment size for Wellington Management?▸

Wellington Management's average investment size is $277.6M across its portfolio of 282 companies.

What are Wellington Management's most recent investments?▸

Recent Wellington Management portfolio additions include Kalshi, Arcus Biosciences, Disc Medicine, Nscale, Beta Bionics. These companies were founded in 2020 or later.

Reach the founders behind these 282 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →